Examination Report |
1 | TM-A(TRADE MARKS APPLICATION) | 12 Oct 2021 |
2 | Reply to Exam Report (MIS-R) | 20 Dec 2021 |
3 | Documents in support of Show cause Hearing (SCH) | 25 Jan 2024 |
4 | Journal Copy | 10 Jun 2024 |
5 | TM-O(NOTICE OF OPPOSITION) | 12 Jun 2024 |
1 | EXAMINATION REPORT | 12510159 | 22 Nov 2021 | |
2 | Hearing Notice (Show Cause) | 16972942 | 29 Dec 2023 | |
3 | Tribunal Accepted Notice for : 5170670 | 17245351 | 6498259 | 29 Jan 2024 |
4 | Opposition Notice | 18752033 | 6883536 | 26 Aug 2024 |
The application for Getacin was made on 12 October 2021.
The trademark applicant for Getacin is BLISS GVS PHARMA.
Getacin is applied in class(es) 5.
Application for Getacin is on Opposed stage.
Application Id allotted to Getacin is 5170670.
Trademark agent or attorney for the application is Innovative Consultants.
Getacin filed with the Intellectual property office as a WORD.